MeSH term
Frequency | Condition_Probility | English Abstract | 3 | 0.0 |
Humans | 91 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
*Mutation | 8 | 0.0 |
*Nerve Tissue Proteins | 23 | 5.0 |
*Repressor Proteins | 20 | 1.0 |
Research Support, Non-U.S. Gov't | 96 | 0.0 |
Transcription Factors/*genetics | 7 | 0.0 |
*Xenopus Proteins | 22 | 6.0 |
Animals | 102 | 0.0 |
*Membrane Proteins | 3 | 0.0 |
Mice | 64 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 57 | 0.0 |
Base Sequence | 17 | 0.0 |
Child, Preschool | 4 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Holoprosencephaly/etiology | 2 | 100.0 |
Male | 18 | 0.0 |
Membrane Proteins/genetics/metabolism | 12 | 9.0 |
Molecular Sequence Data | 18 | 0.0 |
Mutation, Missense | 4 | 0.0 |
Sequence Deletion | 4 | 0.0 |
Signal Transduction/genetics | 5 | 1.0 |
DNA Primers | 2 | 0.0 |
Mice, Inbred C3H | 7 | 1.0 |
Mice, Transgenic | 14 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Trans-Activators/*physiology | 4 | 1.0 |
Cell Division | 8 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Signal Transduction | 23 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Child | 4 | 0.0 |
Holoprosencephaly/*genetics | 6 | 33.0 |
Infant | 5 | 0.0 |
Membrane Proteins/*genetics/metabolism | 3 | 1.0 |
Trans-Activators/*metabolism | 9 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Body Patterning/*physiology | 4 | 22.0 |
Gene Expression Profiling | 3 | 0.0 |
Mesoderm | 2 | 6.0 |
Mutation | 16 | 0.0 |
Signal Transduction/physiology | 5 | 0.0 |
Comparative Study | 3 | 0.0 |
Trans-Activators/genetics/*physiology | 4 | 4.0 |
DNA-Binding Proteins/deficiency/genetics/*physiology | 2 | 8.0 |
Extremities/*embryology | 6 | 20.0 |
Feedback | 3 | 1.0 |
Gene Expression Regulation, Developmental/*physiology | 3 | 2.0 |
*Intercellular Signaling Peptides and Proteins | 6 | 1.0 |
Mice, Knockout | 11 | 0.0 |
Proteins/genetics/physiology | 4 | 6.0 |
Transcription Factors/deficiency/genetics/*physiology | 2 | 11.0 |
Zinc Fingers | 7 | 1.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Female | 19 | 0.0 |
Gene Expression | 12 | 0.0 |
Middle Aged | 4 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
Trans-Activators/genetics/metabolism | 3 | 1.0 |
Body Patterning | 6 | 9.0 |
Signal Transduction/*physiology | 4 | 0.0 |
Adult | 7 | 0.0 |
DNA Mutational Analysis | 8 | 0.0 |
Exons | 3 | 0.0 |
Gestational Age | 4 | 0.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Introns | 2 | 0.0 |
Pregnancy | 4 | 0.0 |
Repressor Proteins/*genetics | 3 | 1.0 |
Treatment Outcome | 2 | 0.0 |
Cell Communication | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Veratrum Alkaloids/pharmacology | 5 | 55.0 |
Mice, Mutant Strains | 10 | 1.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Nervous System/*embryology | 2 | 6.0 |
Oncogene Proteins/*genetics | 3 | 2.0 |
Spinal Cord/embryology | 2 | 11.0 |
Trans-Activators/genetics | 2 | 0.0 |
Biological Markers | 3 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Proteins/metabolism | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Coculture Techniques | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Models, Biological | 5 | 0.0 |
Morphogenesis | 6 | 2.0 |
Trans-Activators/*genetics/metabolism | 3 | 2.0 |
Transfection | 8 | 0.0 |
Gene Expression Regulation, Developmental/physiology | 4 | 5.0 |
Gene Expression Regulation | 4 | 0.0 |
*Receptors, G-Protein-Coupled | 5 | 1.0 |
*Signal Transduction | 12 | 0.0 |
Neurons/cytology/drug effects/*metabolism | 2 | 5.0 |
Organ Culture Techniques | 8 | 2.0 |
Transcription Factors/genetics/metabolism | 5 | 1.0 |
Cell Differentiation | 6 | 0.0 |
Central Nervous System/embryology | 2 | 11.0 |
DNA-Binding Proteins/genetics | 6 | 0.0 |
Down-Regulation | 3 | 0.0 |
Gene Expression Regulation, Developmental | 22 | 2.0 |
In Situ Hybridization | 21 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Transcription Factors/genetics | 6 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Bone Morphogenetic Proteins/metabolism | 3 | 5.0 |
COS Cells | 5 | 0.0 |
Cell Line | 8 | 0.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
Proteins/genetics/*physiology | 7 | 5.0 |
*Trans-Activators | 45 | 7.0 |
Fetal Death/genetics | 2 | 9.0 |
Holoprosencephaly/epidemiology/*genetics | 2 | 100.0 |
Trans-Activators/*genetics | 7 | 2.0 |
Gene Expression Regulation, Developmental/drug effects | 2 | 7.0 |
Rats | 8 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 8 | 2.0 |
Transcription Factors/genetics/*metabolism | 8 | 1.0 |
Fibroblast Growth Factors/*physiology | 2 | 10.0 |
Neurons/physiology | 2 | 1.0 |
*Fetal Proteins | 2 | 9.0 |
*Gene Expression Regulation, Developmental | 10 | 1.0 |
*Glycoproteins | 3 | 0.0 |
Mesoderm/*physiology | 2 | 8.0 |
Sequence Alignment | 3 | 0.0 |
Time Factors | 5 | 0.0 |
*Transcription Factors | 5 | 0.0 |
Abnormalities, Multiple/*genetics/pathology | 2 | 2.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Family Health | 2 | 0.0 |
Heart Defects, Congenital/pathology | 2 | 20.0 |
Pedigree | 3 | 0.0 |
Point Mutation | 2 | 0.0 |
Proteins/*genetics | 8 | 0.0 |
Syndrome | 4 | 0.0 |
Body Patterning/genetics | 5 | 17.0 |
Cell Division/genetics | 3 | 0.0 |
Chick Embryo | 16 | 3.0 |
*Membrane Glycoproteins | 3 | 0.0 |
Notochord | 2 | 100.0 |
Proteins/*metabolism | 7 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Limb Bud | 2 | 28.0 |
Membrane Proteins/metabolism | 5 | 0.0 |
Kidney/abnormalities | 2 | 10.0 |
Proteins/genetics | 2 | 0.0 |
Transcription Factors/biosynthesis | 2 | 2.0 |
Bone Morphogenetic Proteins/*metabolism | 2 | 4.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Embryo/cytology/metabolism | 2 | 10.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Binding Sites | 4 | 0.0 |
Drosophila | 2 | 0.0 |
Gene Deletion | 4 | 0.0 |
Genotype | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
*Embryonic Induction | 3 | 14.0 |
Proteins/*genetics/metabolism | 5 | 1.0 |
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane | 2 | 66.0 |
Cloning, Molecular | 8 | 0.0 |
Homeodomain Proteins/metabolism | 4 | 4.0 |
Regeneration | 2 | 3.0 |
*Carrier Proteins | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Up-Regulation | 6 | 0.0 |
Proteins/physiology | 3 | 2.0 |
Embryonic Induction | 5 | 15.0 |
Proteins/*physiology | 3 | 1.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Mice, Inbred Strains | 4 | 0.0 |
*Protein Biosynthesis | 3 | 0.0 |
Body Patterning/physiology | 2 | 18.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
*Zebrafish Proteins | 3 | 1.0 |
*Zinc Fingers | 2 | 0.0 |
Bone Morphogenetic Proteins/genetics/metabolism | 2 | 16.0 |
Gene Expression Regulation, Developmental/*genetics | 3 | 3.0 |
Mesoderm/metabolism | 7 | 8.0 |
Alleles | 3 | 0.0 |
Embryonic and Fetal Development | 5 | 1.0 |
Extremities/embryology | 3 | 8.0 |
Oncogene Proteins/genetics/*metabolism | 3 | 6.0 |
Proteins/genetics/*metabolism | 3 | 0.0 |
Homeodomain Proteins/genetics | 3 | 1.0 |
DNA Primers/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*Transforming Growth Factor beta | 9 | 6.0 |
Exons/genetics | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Chickens | 2 | 0.0 |
Culture Techniques | 3 | 0.0 |
Ectoderm/physiology | 2 | 14.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Xenopus laevis | 3 | 0.0 |
Bone Morphogenetic Proteins/genetics | 4 | 12.0 |
Embryonic Induction/genetics | 2 | 20.0 |
Membrane Proteins/genetics | 5 | 1.0 |
*Gene Expression | 2 | 0.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Nervous System/embryology | 3 | 9.0 |
Neurons/cytology/*metabolism | 2 | 2.0 |
Species Specificity | 3 | 0.0 |
*Drosophila Proteins | 5 | 0.0 |
Polydactyly/genetics | 3 | 14.0 |
Adolescent | 2 | 0.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Introns/genetics | 3 | 0.0 |
Embryonic Induction/*genetics | 3 | 33.0 |
Homeodomain Proteins/genetics/metabolism | 4 | 5.0 |
Proteins/genetics/metabolism | 3 | 1.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Transcription Factors/genetics/physiology | 2 | 3.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
Oncogene Proteins/genetics/metabolism | 4 | 12.0 |
Transcription Factors/genetics/metabolism/*physiology | 2 | 3.0 |
Embryonic and Fetal Development/*genetics | 3 | 3.0 |
Homeodomain Proteins/biosynthesis | 2 | 12.0 |
Tail/*embryology | 2 | 100.0 |
Tooth/*embryology | 2 | 50.0 |
Gene Expression Regulation, Developmental/genetics | 4 | 4.0 |
Polydactyly/*genetics | 2 | 9.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Holoprosencephaly/*genetics/pathology | 2 | 50.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Epithelial Cells/cytology/metabolism | 2 | 3.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Stem Cells/cytology/*metabolism | 2 | 5.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Receptors, Cell Surface/*genetics/metabolism | 2 | 2.0 |
Cell Line, Tumor | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Cell Transplantation | 2 | 2.0 |
Receptors, Cell Surface/genetics/*metabolism | 2 | 1.0 |
Genes, Homeobox | 3 | 3.0 |
Stem Cells/cytology/metabolism | 2 | 4.0 |
Bone Morphogenetic Proteins/pharmacology | 2 | 6.0 |
Abnormalities, Multiple/embryology/*genetics | 2 | 16.0 |
*Transcription, Genetic | 2 | 0.0 |
Transgenes | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Embryo/metabolism | 2 | 1.0 |
Cell Division/physiology | 2 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Trans-Activators/pharmacology | 2 | 16.0 |
Cell Death | 2 | 0.0 |
